The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia

Pain

Volumn 87, Issue 2, 2000, Pages 121-129

  Wu, Christopher L ^a   Marsh, Ann ^b   Dworkin, Robert H ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Herpes zoster; Nerve block; Pain; Postherpetic neuralgia; Sympathetic nerves

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIVIRUS AGENT; BUPIVACAINE; CLONIDINE; LOCAL ANESTHETIC AGENT; PHENTOLAMINE; PROCAINE;

ADRENERGIC SYSTEM; ANALGESIA; CLINICAL TRIAL; DRUG EFFICACY; HERPES ZOSTER; HUMAN; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVIEW; SYMPATHETIC BLOCKING;

ADRENERGIC FIBERS; ANESTHETICS, LOCAL; AUTONOMIC NERVE BLOCK; HERPES ZOSTER; HUMANS; NEURALGIA;

EID: 0034254888     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00230-X     Document Type: Review

References (70)

1. Arnold J.M.O., Teasell R.W., MacLeod A.P., Brown J.E., Carruthers S.G. Increased venous alpha-adrenergic responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med. 118:1993;619-621.
2. Baron R., Saguer M. Postherpetic neuralgia: are C-nociceptors involved in signaling and maintenance of tactile allodynia? Brain. 116:1993;1477-1496.
3. Bennett G.J. Hypothesis on the pathogenesis of herpes zoster-associated pain. Ann Neurol. 35:1994;S38-S41.
4. Beutner K.R., Friedman D.J., Forszpaniak C., Andersen P.L., Wood M.J. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 39:1995;1546-1553.
5. Boas R.A. Sympathetic nerve blocks: in search of a role. Reg Anesth Pain Med. 23:1998;292-305.
6. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 13:1997;327-331.
7. Campbell J.N., Raja S.N., Belzberg A.J., Meyer R.A. Hyperalgesia and the sympathetic nervous system. Boivie J., Hansson P., Lindblom U. Touch, temperature, and pain in health and disease: mechanisms and assessments. 1994;249-265 IASP Press, Seattle.
8. Choi B., Rowbotham M.C. Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain. 69:1997;55-63.
9. Chung K., Yoon Y.W., Chung J.M. Sprouting sympathetic fibers form synaptic varicosities in the dorsal root ganglion of the rat with neuropathic injury. Brain Res. 751:1997;275-280.
10. Colding A. The effect of regional sympathetic blocks in the treatment of herpes zoster. Acta Anaesth Scand. 13:1969;133-141.
11. Colding A. Treatment of pain: organization of a pain clinic: treatment of acute herpes zoster. Proc R Soc Med. 66:1973;541-543.
12. Dan K. Nerve block therapy and postherpetic neuralgia. Crit Rev Phys Rehab Med. 7:1995;93-112.
13. Dellemijn P.L.I., Fields H.L., Allen R.R., McKay W.R., Rowbotham M.C. The interpretation of pain relief and sensory changes following sympathetic blockade. Brain. 117:1994;1475-1487.
14. Devor M., Jänig W., Michaelis M. Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats. J Neurophysiol. 71:1994;38-47.
15. Dworkin R.H. Prevention of postherpetic neuralgia. Lancet. 353:1999;1636-1637.
16. Dworkin R.H., Banks S.M. A vulnerability-diathesis-stress model of chronic pain: herpes zoster and the development of postherpetic neuralgia. Gatchel R.J., Turk D.C. Psychosocial factors in pain: critical perspectives. 1999;247-269 Guilford, New York.
17. Dworkin R.H., Johnson R.W. A belt of roses from hell: pain in herpes zoster and postherpetic neuralgia. Block A.R., Kremer E.F., Fernandez E. Handbook of pain syndromes: biopsychosocial perspectives. 1999;371-402 Erlbaum, Hillsdale, NJ.
18. Dworkin R.H., Portenoy R.K. Pain and its persistence in herpes zoster. Pain. 67:1996;241-251.
19. Dworkin R.H., Carrington D., Cunningham A., Kost R.G., Levin M.J., McKendrick M.W., Oxman M.N., Rentier B., Schmader K.E., Tspeiner G., Wassilew S.W., Whitley R.J. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res. 33:1997;73-85.
20. Dworkin R.H., Boon R.J., Griffin D.R.G., Phung D. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis. 178:1998;S76-S80.
21. Fields H.L., Rowbotham M., Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis. 5:1998;209-227.
22. Fine P.G. Nerve blocks, herpes zoster, and postherpetic neuralgia. Watson C.P.N. Herpes zoster and postherpetic neuralgia. 1993;173-183 Elsevier, Amsterdam.
23. Haanpaa M., Dastidar P., Weinberg A., Levin M., Miettinen A., Lapinlampi A., Laippala P., Nurmikko T. CSF and MRI findings in patients with acute herpes zoster. Neurology. 51:1998;1405-1411.
24. Hogan Q.H. The sympathetic nervous system in post-herpetic neuralgia. Reg Anesth. 18:1993;271-273.
25. Hogan Q.H., Abram S.E. Neural blockade for diagnosis and prognosis. Anesthesiology. 86:1997;216-241.
26. Hogan Q.H., Erickson S.J., Haddox J.D., Abram S.E. The spread of solutions during stellate ganglion block. Reg Anesth. 17:1992;78-83.
27. Hogan Q.H., Taylor M.L., Goldstein M., Stevens R., Kettler R. Success rates in producing sympathetic blockade by paratracheal injection. Clin J Pain. 10:1994;139-145.
28. Jackson J.L., Gibbons R., Meyer G., Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta-analysis. Arch Intern Med. 157:1997;909-912.
29. Jänig W., McLachlan E.M. The role of modifications in noradrenergic peripheral pathways after nerve lesions in the generation of pain. Fields H.L., Liebeskind J.C. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues. 1994;101-128 IASP Press, Seattle.
30. Jänig W., Levine J.D., Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res. 113:1996;161-184.
31. Johnson R.W. Herpes zoster and postherpetic neuralgia: optimal treatment. Drugs Aging. 10:1997;80-94.
32. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-139.
33. Kinnman E., Levine J.D. Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat. Neuroscience. 65:1995;283-291.
34. Kinnman E., Nygards E.B., Hansson P. Peripheral α-adrenoreceptors are involved in the development of capsaicin induced ongoing and stimulus evoked pain in humans. Pain. 69:1997;79-85.
35. Manabe H., Dan K., Higa K. Continuous epidural infusion of local anesthetics and shorter duration of acute zoster-associated pain. Clin J Pain. 11:1995;220-228.
36. Malmqvist E.L., Bengtsson M., Sorenson J. Efficacy of stellate ganglion block: a clinical study with bupivacaine. Reg Anesth. 17:1992;340-347.
37. McLachlan E.M., Jänig W., Devor M., Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglion. Nature. 363:1993;543-546.
38. Michaelis M., Devor M., Jänig W. Sympathetic modulation of activity in rat dorsal root ganglion neurons changes over time following peripheral nerve injury. J Neurophysiol. 76:1996;753-763.
39. Nurmikko T. Sensory dysfunction in postherpetic neuralgia. Boivie J., Hansson P., Lindblom U. Touch, temperature, and pain in health and disease: mechanisms and assessments. 1994;133-141 IASP Press, Seattle.
40. Nurmikko T., Wells C., Bowsher D. Pain and allodynia in postherpetic neuralgia: role of somatic and sympathetic nervous systems. Acta Neurol Scand. 84:1991;146-152.
41. Perl E.R. Causalgia and reflex sympathetic dystrophy revisited. Boivie J., Hansson P., Lindblom U. Touch, temperature, and pain in health and disease: mechanisms and assessments. 1994;231-248 IASP Press, Seattle.
42. Pierce P.A., Brose W.G. Causalgia/reflex sympathetic dystrophy. Yaksh T.L., Lynch C., Zapol W.M., Maze M., Biebuyck J.F., Saidman L.J. Anesthesia: biologic foundations. 1998;889-904 Lippincott-Raven Publishers, Philadelphia.
43. Raja S.N., Treede R.D., Davis K.D., Campbell J.N. Systemic α-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology. 74:1991;691-698.
44. Riopelle J.M., Naraghi M., Grush K. Chronic neuralgia incidence following local anesthetic therapy for herpes zoster. Arch Dermatol. 120:1984;747-750.
45. Rosenak S. Procaine injection treatment of herpes zoster. Lancet. 2:1938;1056-1058.
46. Rowbotham M.C., Fields H.L. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain. 119:1996;347-354.
47. Rowbotham M.C., Taylor K. Herpes zoster and postherpetic neuralgia. Yaksh T.L., Lynch C., Zapol W.M., Maze M., Biebuyck J.F., Saidman L.J. Anesthesia: biologic foundations. 1998;879-888 Lippincott-Raven Publishers, Philadelphia.
48. Rowbotham M.C., Davies P.S., Fields H.L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 37:1995;246-253.
49. Rowbotham M.C., Petersen K.L., Fields H.L. Is postherpetic neuralgia more than one disorder? Pain Forum. 7:1998;231-237.
50. Rutgers M.J., Dirksen R. The prevention of postherpetic neuralgia: a retrospective view of patients treated in the acute phase of herpes zoster. Br J Clin Prac. 42:1988;412-414.
51. Sato J., Perl E.R. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science. 251:1991;1608-1610.
52. Sato J., Suzuki S., Iseki T., Kumazama T. Adrenergic excitation of cutaneous nociceptors in chronically inflamed rats. Neurosci Lett. 164:1993;225-228.
53. Schott G.D. Visceral afferents: their contribution to 'sympathetic dependent' pain. Brain. 117:1994;397-413.
54. Tanelian D.L., MacIver M.B. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology. 74:1991;934-936.
55. Tenicela R., Lovasik D., Eaglstein W. Treatment of herpes zoster with sympathetic blocks. Clin J Pain. 1:1985;63-67.
56. Treede R.D., Davis K.D., Campbell J.N., Raja S.N. The plasticity of cutaneous hyperalgesia during sympathetic ganglion blockade in patients with neuropathic pain. Brain. 115:1992;607-621.
57. Tyring S., Barbarash R.A., Nahlik J.E., Cunningham A., Marley J., Heng M., Jones T., Rea T., Boon R., Saltzman R. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 123:1995;89-96.
58. Wakisaka S., Kajander K.C., Bennett G.J. Abnormal skin temperature and abnormal sympathetic vasomotor innervation in an experimental painful peripheral neuropathy. Pain. 46:1991;299-313.
59. Wallace M.S., Oxman M.N. Acute herpes zoster and postherpetic neuralgia. Anesth Clin North Am. 15:1997;371-405.
60. Watson C.P.N., Deck J.H. The neuropathology of herpes zoster with particular reference to postherpetic neuralgia and its pathogenesis. Watson C.P.N. Herpes zoster and postherpetic neuralgia. 1993;139-157 Elsevier, Amsterdam.
61. Watson C.P.N., Tyler K.L., Bickers D.R., Millikan L.E., Smith S., Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 15:1993;510-526.
62. Whitley R.J., Weiss H., Gnann J.W. Jr, Tyring S., Mertz G.J., Pappas P.G., Schleupner C.J., Hayden F., Wolf J., Soong S.J. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med. 125:1996;376-383.
63. Whitley R.J., Weiss H.L., Soong S.J., Gnann J.W. Herpes zoster: risk categories for persistent pain. J Infect Dis. 179:1999;9-15.
64. Winnie A.P., Hartwell P.W. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth. 18:1993;277-282.
65. Wood M.J. How should zoster trials be conducted. J Antimicrob Chemother. 36:1995;1089-1101.
66. Wood M.J., Johnson R.W., McKendrick M.W., Taylor J., Mandal B.K., Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 330:1994;896-900.
67. Wood M.J., Kay R., Dworkin R.H., Soong S.J., Whitley R.J. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 22:1996;341-347.
68. Woolf C.J., Shortland P., Coggeshall R.E. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature. 355:1992;75-78.
69. Wulf H., Maier C., Schele H.A., Wabbel W. Plasma concentration of bupivacaine after stellate ganglion blockade. Anesth Analg. 72:1991;546-548.
70. Yanagida H., Suwa K., Corssen G. No prophylactic effect of early sympathetic blockade on postherpetic neuralgia. Anesthesiology. 66:1987;73-76.